How does ace inhibitor work
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action of ACE Inhibitors
Introduction to ACE Inhibitors
Angiotensin-converting enzyme (ACE) inhibitors are a class of medications widely used to treat cardiovascular and renal diseases, including hypertension, heart failure, and diabetic complications. They work by modulating the balance between vasoconstrictive and vasodilatory peptides, primarily angiotensin II (Ang II) and bradykinin, respectively 12.
Inhibition of Angiotensin II Production
Vasoconstriction and Blood Pressure Regulation
ACE inhibitors block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing Ang II levels, these inhibitors decrease systemic vascular resistance, which helps lower blood pressure without increasing heart rate 14. This mechanism is particularly beneficial in managing hypertension and reducing the risk of cardiovascular events such as myocardial infarction and stroke 910.
Cardiac and Renal Protection
In addition to lowering blood pressure, ACE inhibitors reduce cardiac hypertrophy and fibrosis by inhibiting Ang II-mediated pathways. This effect is crucial in preventing the progression of heart failure and left ventricular dysfunction . They also delay the progression of diabetic nephropathy by reducing glomerular pressure and proteinuria 19.
Enhancement of Bradykinin Levels
Vasodilation and Natriuresis
ACE inhibitors increase the levels of bradykinin, a vasodilatory peptide, by preventing its breakdown. Elevated bradykinin levels lead to enhanced vasodilation and natriuresis, further contributing to blood pressure reduction 12. This dual action on Ang II and bradykinin makes ACE inhibitors effective in managing cardiovascular diseases .
Anti-inflammatory and Antioxidant Effects
Bradykinin also has anti-inflammatory and antioxidant properties. By increasing bradykinin levels, ACE inhibitors help reduce oxidative stress and inflammation, which are critical factors in the progression of cardiovascular and renal diseases 15.
Modulation of Metabolic Control
Insulin Sensitivity and Glucose Metabolism
ACE inhibitors have been shown to improve insulin sensitivity and glucose metabolism, making them beneficial for patients with insulin resistance and type 2 diabetes. They enhance glucose uptake in skeletal muscle by increasing nitric oxide (NO) production and upregulating insulin signaling pathways . This effect helps in better glucose control and reduces the risk of developing diabetes-related complications .
Novel Mechanisms and Emerging Insights
Allosteric Enhancement of Kinin Receptors
Recent studies have revealed that ACE inhibitors can act as allosteric enhancers of kinin B1 and B2 receptors. This action potentiates the effects of bradykinin, leading to increased NO production and further vasodilation . These findings suggest additional therapeutic benefits of ACE inhibitors beyond their traditional roles.
Inhibition of Ac-SDKP Hydrolysis
Another novel mechanism involves the inhibition of N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) hydrolysis. This inhibition reduces cardiac fibrosis and cell proliferation, providing a protective effect against cardiac remodeling in hypertensive conditions .
Conclusion
ACE inhibitors are multifaceted drugs that offer a range of therapeutic benefits by modulating the renin-angiotensin-aldosterone system and enhancing bradykinin levels. Their ability to lower blood pressure, protect cardiac and renal function, and improve metabolic control makes them indispensable in the management of cardiovascular and renal diseases. Ongoing research continues to uncover new mechanisms, further expanding their potential clinical applications.
Sources and full results
Most relevant research papers on this topic